SCHEMBL7973683

SCHEMBL7973683

C1=CCC(COCC2CC=CCC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.56
ALDH1A1 P00352 5/20 0.40
LMNA P02545 4/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNA2 P20248 2/20 0.40
CDK2 P24941 2/20 0.40
CCNA1 P78396 2/20 0.40
HTT P42858 2/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
KDM4E B2RXH2 5/20 0.35
APOBEC3A P31941 2/20 0.35
APOBEC3G Q9HC16 2/20 0.35
RGS12 O14924 2/20 0.35
PABPC1 P11940 1/20 0.35
EIF4H Q15056 1/20 0.35
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260723 0.91 MAPK1 (0.49) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL12286212 0.87 MAPK1 (0.46) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL472171 0.87 MAPK1 (0.46) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL16480957 0.87 MAPK1 (0.46) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL14241127 0.87 MAPK1 (0.46) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL13460203 0.86 MAPK1 (0.57) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL13895288 0.83 MAPK1 (0.44) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL7927729 0.82 ALDH1A1 (0.44) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL19695510 0.82 ALDH1A1 (0.44) MAPK1ALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL1715525 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190153354-A1 FRAGRANCE MATERIAL TAKASAGO INTERNATIONAL CORPORATION (JP) 2019-05-23 US claimed
EP-3468526-A1 FRAGRANCE MATERIAL Takasago International Corporation (JP) 2019-04-17 EP claimed
WO-2017214455-A1 FRAGRANCE MATERIAL TAKASAGO INTERNATIONAL CORPORATION (USA) (US) 2017-12-14 WO claimed
EP-3468526-B1 FRAGRANCE MATERIAL TAKASAGO PERFUMERY CO LTD (JP) 2021-05-12 EP disclosed
EP-3468526-B1 FRAGRANCE MATERIAL TAKASAGO PERFUMERY CO LTD (JP) 2021-05-12 EP disclosed
US-10745646-B2 Fragrance material TAKASAGO INTERNATIONAL CORPORATION (JP) 2020-08-18 US disclosed
US-10745646-B2 Fragrance material TAKASAGO INTERNATIONAL CORPORATION (JP) 2020-08-18 US disclosed
US-20190153354-A1 FRAGRANCE MATERIAL TAKASAGO INTERNATIONAL CORPORATION (JP) 2019-05-23 US disclosed
US-20190153354-A1 FRAGRANCE MATERIAL TAKASAGO INTERNATIONAL CORPORATION (JP) 2019-05-23 US disclosed
EP-3468526-A1 FRAGRANCE MATERIAL Takasago International Corporation (JP) 2019-04-17 EP disclosed
WO-2017214455-A1 FRAGRANCE MATERIAL TAKASAGO INTERNATIONAL CORPORATION (USA) (US) 2017-12-14 WO disclosed
US-20160177023-A1 CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID CHANG CHUN PLASTICS CO., LTD. (TW) 2016-06-23 US disclosed
US-20160177023-A1 CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID CHANG CHUN PLASTICS CO., LTD. (TW) 2016-06-23 US disclosed
US-20160122466-A1 CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND DAICEL CORPORATION (JP) 2016-05-05 US disclosed
US-20160122466-A1 CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND DAICEL CORPORATION (JP) 2016-05-05 US disclosed
US-20160083360-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS CHANG CHUN PLASTICS CO., LTD. (TW) 2016-03-24 US disclosed
US-20160083360-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS CHANG CHUN PLASTICS CO., LTD. (TW) 2016-03-24 US disclosed
US-20160083360-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS CHANG CHUN PLASTICS CO., LTD. (TW) 2016-03-24 US disclosed
US-6268403-B1 CYCLOALIPHATIC EPOXYALCOHOL MONOMERS RENSSELAER POLYTECHNIC INSTITUTE 2001-07-31 US disclosed
WO-1999041296-A1 PHOTOPOLYMERIZABLE COMPOSITIONS CONTAINING CYCLOALIPHATIC EPOXYALCOHOL MONOMERS RENSSELAER POLYTECHNIC INSTITUTE (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122466-A1 CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND EEF1A1, EEF2, EEF1A2 MAPK1 2981/4885ALDH1A1 296/4885LMNA 1543/4885
US-10745646-B2 Fragrance material TRPA1, TRPV1, NISCH MAPK1 3927/4885ALDH1A1 297/4885LMNA 1453/4885
US-20160083360-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS HSF1, HMOX1, HSPH1 MAPK1 1550/4885ALDH1A1 508/4885LMNA 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.